fax: (33) 2 47 47 82 07.
Article first published online: 14 MAR 2013
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 57, Issue 4, pages 1303–1313, April 2013
How to Cite
Beaumont, E., Patient, R., Hourioux, C., Dimier-Poisson, I. and Roingeard, P. (2013), Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine. Hepatology, 57: 1303–1313. doi: 10.1002/hep.26132
Potential conflict of interest: Nothing to report.
This study was supported by the Institut Mérieux, the “Hepatibivax” grant from the “Emergence” program of the Agence Nationale pour la Recherche (France), and the FEDER (Fonds Européens de Développements en Region–Région Centre, France) program. The authors thank Dr. Takaji Wakita for the JFH-1 virus strain, Dr. Jens Bukh for the chimeric JFH-1 genomes, S52/JFH1, H77/JFH1, and J4/JFH1, Dr. Charles Rice for the Huh7.5 cell line, Dr. Jonathan Ball for the UKN5.23, UKN 2a1.2, and UKN3A.1.28 plasmids, Dr. Jean Dubuisson for the 7a plasmid and the mAb H52, Dr Harry Greenberg for the mAb A4, Dr. Camille Sureau for the polyclonal anti-HBs Ab, R247, and Dr. Mansun Law for the mAbs, AR3A and AR5A.
- Issue published online: 8 APR 2013
- Article first published online: 14 MAR 2013
- Accepted manuscript online: 13 NOV 2012 11:01PM EST
- Manuscript Revised: 17 OCT 2012
- Manuscript Accepted: 17 OCT 2012
- Manuscript Received: 31 MAY 2012
Additional Supporting Information may be found in the online version of this article.
|HEP_26132_sm_SuppFig1.tif||14110K||Supporting Information Figure 1.|
|HEP_26132_sm_SuppFig2.tif||18210K||Supporting Information Figure 2.|
|HEP_26132_sm_SuppFig3.tif||504K||Supporting Information Figure 3.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.